Exscientia plc (EXAI)
After hours:
| Previous close | 5.0900 |
| Open | 5.2100 |
| Bid | 4.6400 x 100 |
| Ask | 4.7100 x 400 |
| Day's range | 4.6700 - 5.2400 |
| 52-week range | 3.8600 - 9.1200 |
| Volume | |
| Avg. volume | 758,808 |
| Market cap | 590.171M |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Exscientia plc's (NASDAQ:EXAI) market cap touched US$797m last week, benefiting both individual investors who own 48% as well as institutions
Key Insights Exscientia's significant individual investors ownership suggests that the key decisions are influenced by...
- The Telegraph
Oxford drug company sacks chief executive over ‘inappropriate’ relationships with staff
The chief executive and founder of an Oxford-based drug company has been sacked over “inappropriate” relationships with colleagues.
- Reuters
Exscientia fires CEO after probe over relationship with two employees
British biotech Exscientia Plc said on Tuesday it had dismissed CEO Andrew Hopkins after an investigation found that his relationship with two employees was "inconsistent with the company's standards and values". Exscientia said a special committee of its board had engaged an outside counsel to look into Hopkins' conduct. The company said Chairman David Nicholson resigned from the board on Feb. 12 after it was discovered during the investigation that Nicholson had prior knowledge about one of Hopkins' relationships.
